Gastric Banding After Failed Gastric Bypass

June 18, 2020 updated by: Duomed

Laparoscopic Adjustable Gastric Banding With the Adhesix Bioring After Failed Gastric Bypass: a Prospective Evaluation in a High-volume Center

The safety and efficacy of the Adhesix Bioring adjustable gastric band will be assessed in patients after failed RYGB.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

35

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brugge, Belgium
        • AZ Sint Jan Brugge

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with failed RYGB receiving revisional LAGB.

Description

Inclusion Criteria:

  • Patient must sign the informed consent form prior to the index-procedure.
  • Patient with failed RYGB defined as patients with EWL <50%.

Exclusion Criteria:

  • Patient has a life expectancy of less than 2 year.
  • Patient who is most likely expected not to be compliant with the proposed follow-up visits.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients with failed RYGB (EWL <50%)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Percentage excess weight loss
Time Frame: 2 years
2 years

Secondary Outcome Measures

Outcome Measure
Time Frame
Mortality
Time Frame: 2 years
2 years
Technical success defined as laparoscopic implantation of the Adhesix Bioring as intended by the surgeon without conversion to open repair.
Time Frame: During procedure
During procedure
Complications (perioperative, early and late)
Time Frame: 2 years
2 years
Regression of co-morbidities
Time Frame: 2 years
2 years
BAROS score
Time Frame: 2 years
2 years
Frequency of revisions
Time Frame: 2 years
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Bruno Dillemans, MD, AZ Sint-Jan AV

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2015

Primary Completion (Actual)

December 9, 2019

Study Completion (Actual)

December 9, 2019

Study Registration Dates

First Submitted

July 15, 2015

First Submitted That Met QC Criteria

August 18, 2015

First Posted (Estimate)

August 19, 2015

Study Record Updates

Last Update Posted (Actual)

June 18, 2020

Last Update Submitted That Met QC Criteria

June 18, 2020

Last Verified

February 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • BM-BA-01

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Adhesix Bioring

Subscribe